Literature DB >> 35465723

Nutrient Limitation Magnifies Fitness Costs of Antimalarial Drug Resistance Mutations.

Shalini Nair1, Xue Li1, Grace A Arya1, Marina McDew-White1, Marco Ferrari1, Tim Anderson1.   

Abstract

Drug resistance mutations tend to disrupt key physiological processes and frequently carry fitness costs, which are a central determinant of the rate of spread of these mutations in natural populations. Head-to-head competition assays provide a standard approach to measuring fitness for malaria parasites. These assays typically use a standardized culture medium containing RPMI 1640, which has a 1.4- to 5.5-fold higher concentration of amino acids than human blood. In this rich medium, we predict that fitness costs will be underestimated because resource competition is weak. We tested this prediction using an artemisinin-sensitive parasite edited to contain kelch-C580Y or R561H mutations conferring resistance to artemisinin or synonymous control mutations. We examined the impact of these single amino acid mutations on fitness, using replicated head-to-head competition experiments conducted in media containing (i) normal RPMI, (ii) modified RPMI with reduced amino acid concentration, (iii) RPMI containing only isoleucine, or (iv) 3-fold diluted RPMI. We found a significant 1.3- to 1.4-fold increase in fitness costs measured in modified and isoleucine-only media relative to normal media, while fitness costs were 2.5-fold higher in diluted media. We conclude that fitness costs are strongly affected by media composition and will be significantly underestimated in normal RPMI. Several components differed between media, including pABA and sodium bicarbonate concentrations, so we cannot directly determine which is responsible. Elevated fitness costs in nature will limit spread of artemisinin (ART) resistance but will also promote evolution of compensatory mutations that restore fitness and can be exploited to maximize selection in laboratory experiments.

Entities:  

Keywords:  Plasmodium falciparum; artemisinin; artemisinin resistance; compensation; compensatory mutation; competition; fitness costs; nutrient limitation; resource limitation

Mesh:

Substances:

Year:  2022        PMID: 35465723      PMCID: PMC9112896          DOI: 10.1128/aac.01529-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.938


  42 in total

1.  Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance.

Authors:  J Björkman; I Nagaev; O G Berg; D Hughes; D I Andersson
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

2.  Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems.

Authors:  Jun Liu; Eva S Istvan; Ilya Y Gluzman; Julia Gross; Daniel E Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-26       Impact factor: 11.205

3.  Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.

Authors:  James G Kublin; Joseph F Cortese; Eric Mbindo Njunju; Rabia A G Mukadam; Jack J Wirima; Peter N Kazembe; Abdoulaye A Djimdé; Bourema Kouriba; Terrie E Taylor; Christopher V Plowe
Journal:  J Infect Dis       Date:  2003-05-21       Impact factor: 5.226

4.  A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites.

Authors:  Jakob Birnbaum; Sarah Scharf; Sabine Schmidt; Ernst Jonscher; Wieteke Anna Maria Hoeijmakers; Sven Flemming; Christa Geeke Toenhake; Marius Schmitt; Ricarda Sabitzki; Bärbel Bergmann; Ulrike Fröhlke; Paolo Mesén-Ramírez; Alexandra Blancke Soares; Hendrik Herrmann; Richárd Bártfai; Tobias Spielmann
Journal:  Science       Date:  2020-01-03       Impact factor: 47.728

Review 5.  Insights gained from P. falciparum cultivation in modified media.

Authors:  Sanjay A Desai
Journal:  ScientificWorldJournal       Date:  2013-07-09

6.  Evolution of Fitness Cost-Neutral Mutant PfCRT Conferring P. falciparum 4-Aminoquinoline Drug Resistance Is Accompanied by Altered Parasite Metabolism and Digestive Vacuole Physiology.

Authors:  Stanislaw J Gabryszewski; Satish K Dhingra; Jill M Combrinck; Ian A Lewis; Paul S Callaghan; Matthew R Hassett; Amila Siriwardana; Philipp P Henrich; Andrew H Lee; Nina F Gnädig; Lise Musset; Manuel Llinás; Timothy J Egan; Paul D Roepe; David A Fidock
Journal:  PLoS Pathog       Date:  2016-11-10       Impact factor: 6.823

7.  Fitness Costs and the Rapid Spread of kelch13-C580Y Substitutions Conferring Artemisinin Resistance.

Authors:  Shalini Nair; Xue Li; Grace A Arya; Marina McDew-White; Marco Ferrari; François Nosten; Tim J C Anderson
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

8.  Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine.

Authors:  Leila S Ross; Satish K Dhingra; Sachel Mok; Tomas Yeo; Kathryn J Wicht; Krittikorn Kümpornsin; Shannon Takala-Harrison; Benoit Witkowski; Rick M Fairhurst; Frederic Ariey; Didier Menard; David A Fidock
Journal:  Nat Commun       Date:  2018-08-17       Impact factor: 14.919

9.  Balanced impacts of fitness and drug pressure on the evolution of PfMDR1 polymorphisms in Plasmodium falciparum.

Authors:  Marvin Duvalsaint; Melissa D Conrad; Stephen Tukwasibwe; Patrick K Tumwebaze; Jennifer Legac; Roland A Cooper; Philip J Rosenthal
Journal:  Malar J       Date:  2021-06-30       Impact factor: 2.979

10.  Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda.

Authors:  Aline Uwimana; Eric Legrand; Barbara H Stokes; Jean-Louis Mangala Ndikumana; Marian Warsame; Noella Umulisa; Daniel Ngamije; Tharcisse Munyaneza; Jean-Baptiste Mazarati; Kaendi Munguti; Pascal Campagne; Alexis Criscuolo; Frédéric Ariey; Monique Murindahabi; Pascal Ringwald; David A Fidock; Aimable Mbituyumuremyi; Didier Menard
Journal:  Nat Med       Date:  2020-08-03       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.